ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 771

Development of a Bifluorescent Lineage Tracker Reporter Mouse Strain to Analyze the Phenotypic Conversion of Endothelial Cells into Myofibroblasts in Vivo. Application to Study the Synergistic Effects of Endothelin-1 on TGF-β1-Induced Endothelial-to-Mesenchymal Transition

Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, endothelial cells, Fibroblasts, fibrosis and scleroderma

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Endothelial-to-mesenchymal transition (EndoMT) may be a crucial pathway in generating activated myofibroblasts, cells that play a pivotal role in the development of tissue and organ fibrosis in diseases such as Systemic Sclerosis (SSc).  It has been previously demonstrated that endothelin 1 (ET-1) synergistically enhances TGF-β-induced EndoMT in vitro in murine lung endothelial cells (ECs). The purpose of this study was to develop a mouse model expressing a green distinct fluorescent label in ECs (green fluorescent protein; GFP) and a red fluorescent label in fibroblasts (mCherry protein) to allow monitoring of EndoMT in vivo.

Methods: Homozygous Tie2GFP transgenic mice expressing GFP under control of the EC specific Tie2 promoter (Tie2GFP mice) were crossed with homozygous mice expressing a doxycycline inducible red fluorescent mCherry protein in mesenchymal cells and fibroblasts under control of the Col1a1 promoter (Col1mCherry mice) to generate heterozygous bifluorescent Tie2GFP-Col1mCherry mice. At 4 weeks of age, osmotic pumps containing either saline, 2.5 µg TGF-β, or 2.5 µg TGF-β+5.0 µg ET-1 were implanted subcutaneously in the right intrascapular region of the mice (2 mice per treatment group).  The pumps deliver their contents at a rate of 0.5 µl/h over a 2 week period. Mice received IP injections of 1 mg/kg doxycycline every other day starting at 2 weeks post-implantation of the pump and were sacrificed one week later. Both lungs and two skin samples, one at the pump dispersal site and one opposite to the pump site, were isolated.  A portion of each tissue was fixed in formalin and processed for histopathologic analysis (hematoxyllin/eosin and Masson’s trichrome stains) whereas another portion was frozen and sectioned for evaluation of fluorescence.  Another sample portion of each tissue was hydrolyzed for measurement of hydroxyproline content.


Results: Histopathology studies in samples from TGF-β-treated mice showed mononuclear cell infiltration and peribronchial fibrosis and diffuse interstitial fibrosis in lungs. Dermal fibrosis was present in both samples of skin.  ET-1 synergistically enhanced the severity of fibrosis in all three tissues.   Hydroxyproline levels in skin taken from the site of the osmotic pump demonstrated a 61% increase in response to TGF-β alone and a 113% increase (~2.2 fold) in response to TGF-β+ET-1 whereas skin from the opposite side of the back displayed a 29% increase in response to TGF-β alone and a 102% increase (~2 fold) in response to TGF-β+ET-1.  In the lung, TGF-β increased hydroxyproline levels by 38% and TGF-β+ET-1 increased hydroxyproline levels by 75%.


Conclusion: Tie2GFP-Col1mCherry mice represent a valuable resource for monitoring EndoMT in vivo. ET-1 plays an important in vivo role in regulating EndoMT by causing a synergistic potentiation of TGF-β1-induced EndoMT. Since ET-1 plays a crucial role in the pathogenesis of SSc-associated pulmonary arterial hypertension and may play a profibrotic role in skin and lung fibrosis, the results described here identify a novel mechanism supporting the concept that ET-1 plays a key pathogenetic role in vivo in SSc-associated tissue fibrosis.


Disclosure:

P. J. Wermuth,
None;

S. A. Jimenez,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-bifluorescent-lineage-tracker-reporter-mouse-strain-to-analyze-the-phenotypic-conversion-of-endothelial-cells-into-myofibroblasts-in-vivo-application-to-study-the-synergistic-effects/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology